These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 15048596)

  • 21. Serum adipokine levels in chronic liver diseases: association of resistin levels with fibrosis severity.
    Tsochatzis E; Papatheodoridis GV; Hadziyannis E; Georgiou A; Kafiri G; Tiniakos DG; Manesis EK; Archimandritis AJ
    Scand J Gastroenterol; 2008; 43(9):1128-36. PubMed ID: 18609175
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Non-alcoholic steatohepatitis].
    Haukeland JW; Konopski Z; Bell H; Raknerud N
    Tidsskr Nor Laegeforen; 2001 Aug; 121(20):2377-80. PubMed ID: 11603045
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatic histopathology of morbid obesity: concurrence of other forms of chronic liver disease.
    Liew PL; Lee WJ; Lee YC; Wang HH; Wang W; Lin YC
    Obes Surg; 2006 Dec; 16(12):1584-93. PubMed ID: 17217634
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum ferritin levels do not predict the stage of underlying non-alcoholic fatty liver disease.
    Chandok N; Minuk G; Wengiel M; Uhanova J
    J Gastrointestin Liver Dis; 2012 Mar; 21(1):53-8. PubMed ID: 22457860
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hepatic iron overload or cirrhosis may occur in acquired copper deficiency and is likely mediated by hypoceruloplasminemia.
    Thackeray EW; Sanderson SO; Fox JC; Kumar N
    J Clin Gastroenterol; 2011 Feb; 45(2):153-8. PubMed ID: 20502350
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Copper availability contributes to iron perturbations in human nonalcoholic fatty liver disease.
    Aigner E; Theurl I; Haufe H; Seifert M; Hohla F; Scharinger L; Stickel F; Mourlane F; Weiss G; Datz C
    Gastroenterology; 2008 Aug; 135(2):680-8. PubMed ID: 18505688
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characteristics and diagnosis of NAFLD/NASH.
    Hashimoto E; Taniai M; Tokushige K
    J Gastroenterol Hepatol; 2013 Dec; 28 Suppl 4():64-70. PubMed ID: 24251707
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A role for low hepatic copper concentrations in nonalcoholic Fatty liver disease.
    Aigner E; Strasser M; Haufe H; Sonnweber T; Hohla F; Stadlmayr A; Solioz M; Tilg H; Patsch W; Weiss G; Stickel F; Datz C
    Am J Gastroenterol; 2010 Sep; 105(9):1978-85. PubMed ID: 20407430
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The importance of routine liver biopsy in diagnosing nonalcoholic steatohepatitis in bariatric patients.
    Shalhub S; Parsee A; Gallagher SF; Haines KL; Willkomm C; Brantley SG; Pinkas H; Saff-Koche L; Murr MM
    Obes Surg; 2004 Jan; 14(1):54-9. PubMed ID: 14980034
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum ferritin is a discriminant marker for both fibrosis and inflammation in histologically proven non-alcoholic fatty liver disease patients.
    Manousou P; Kalambokis G; Grillo F; Watkins J; Xirouchakis E; Pleguezuelo M; Leandro G; Arvaniti V; Germani G; Patch D; Calvaruso V; Mikhailidis DP; Dhillon AP; Burroughs AK
    Liver Int; 2011 May; 31(5):730-9. PubMed ID: 21457446
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Difference and similarity between non-alcoholic steatohepatitis and alcoholic liver disease.
    Kojima H; Sakurai S; Uemura M; Takekawa T; Morimoto H; Tamagawa Y; Fukui H
    Alcohol Clin Exp Res; 2005 Dec; 29(12 Suppl):259S-63S. PubMed ID: 16385233
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Progressive fibrosis in nonalcoholic steatohepatitis: association with altered regeneration and a ductular reaction.
    Richardson MM; Jonsson JR; Powell EE; Brunt EM; Neuschwander-Tetri BA; Bhathal PS; Dixon JB; Weltman MD; Tilg H; Moschen AR; Purdie DM; Demetris AJ; Clouston AD
    Gastroenterology; 2007 Jul; 133(1):80-90. PubMed ID: 17631134
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum iron parameters in cirrhosis and chronic hepatitis: detailed description.
    Büyükaşik NS; Nadır I; Akin FE; Cakal B; Kav T; Ersoy O; Büyükaşik Y
    Turk J Gastroenterol; 2011 Dec; 22(6):606-11. PubMed ID: 22287406
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical and pathological differences between alcoholic hepatitis and non-alcoholic steatohepatitis.
    Sugimoto M; Sadamoto T; Nonaka H
    Nihon Arukoru Yakubutsu Igakkai Zasshi; 2003 Feb; 38(1):34-45. PubMed ID: 12687723
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nonalcoholic steatohepatitis.
    Kumar KS; Malet PF
    Mayo Clin Proc; 2000 Jul; 75(7):733-9. PubMed ID: 10907390
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Liver iron excess in patients with hepatocellular carcinoma developed on non-alcoholic steato-hepatitis.
    Sorrentino P; D'Angelo S; Ferbo U; Micheli P; Bracigliano A; Vecchione R
    J Hepatol; 2009 Feb; 50(2):351-7. PubMed ID: 19070395
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Familial hemochromatosis: characteristics of the precirrhotic stage in a large kindred.
    Rowe JW; Wands JR; Mezey E; Waterbury LA; Wright JR; Tobin J; Andres R
    Medicine (Baltimore); 1977 May; 56(3):197-211. PubMed ID: 870791
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diagnostic efficacy of tests for the detection of iron overload in chronic liver disease.
    Valberg LS; Ghent CN; Lloyd DA; Frei JV; Chamberlain MJ
    Can Med Assoc J; 1978 Aug; 119(3):229-36. PubMed ID: 679127
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum thioredoxin levels as a predictor of steatohepatitis in patients with nonalcoholic fatty liver disease.
    Sumida Y; Nakashima T; Yoh T; Furutani M; Hirohama A; Kakisaka Y; Nakajima Y; Ishikawa H; Mitsuyoshi H; Okanoue T; Kashima K; Nakamura H; Yodoi J
    J Hepatol; 2003 Jan; 38(1):32-8. PubMed ID: 12480557
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum iron parameters in patients with alcoholic and chronic cirrhosis and hepatitis.
    Jurczyk K; Wawrzynowicz-Syczewska M; Boroń-Kaczmarska A; Sych Z
    Med Sci Monit; 2001; 7(5):962-5. PubMed ID: 11535942
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.